Unspecified Anti-Nausea Medication

Verify with FDA CVM →

10 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
10
Total Reports
4
Deaths Reported
4000.0%
Death Rate

Active Ingredients

Unspecified Anti-Nausea Medication

Administration Routes

UnknownOral

Species Affected

Dog 6
Cat 4

Most Affected Breeds

Domestic Shorthair 3
Terrier (unspecified) 2
Schnauzer - Miniature 1
Shepherd Dog - German 1
Crossbred Canine/dog 1
Cat (other) 1
Schnauzer - Giant 1

Most Reported Reactions

Vomiting 4
Diarrhoea 4
Lethargy (see also Central nervous system depression in Neurological) 3
Weight loss 3
Death by euthanasia 3
Lack of efficacy - NOS 1
Underdose 1
Incorrect route of drug administration 1
Bloody diarrhoea 1
Mucous stool 1
Panting 1
Restlessness 1

Outcome Breakdown

Outcome Unknown
3 (30.0%)
Ongoing
3 (30.0%)
Euthanized
3 (30.0%)
Died
1 (10.0%)

Data Summary

Metric Value
Total adverse event reports 10
Reports involving death 4
Case-fatality rate (reported events) 4000.0%
Distinct species in reports 2
Distinct breeds in reports 7
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Unspecified Anti-Nausea Medication Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 10 adverse event reports referencing Unspecified Anti-Nausea Medication, including 4 reports in which the animal died — a 4000.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Unspecified Anti-Nausea Medication. Reported administration routes include Unknown, Oral. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Unspecified Anti-Nausea Medication reports are Dog (6 reports), Cat (4 reports), with Dog accounting for the largest share. Within those species, Domestic Shorthair (3), Terrier (unspecified) (2), Schnauzer - Miniature (1) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Unspecified Anti-Nausea Medication are Vomiting (4), Diarrhoea (4), Lethargy (see also Central nervous system depression in Neurological) (3), Weight loss (3). Of the 10 reports with a coded outcome, Outcome Unknown is the leading category at 30.0%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Unspecified Anti-Nausea Medication.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial